Skip to content

Myeloma Clinical Trials

Academic Myeloma Consortium (AMyC)

Myeloma Clinical Trials

Criterium and The Oncology Consortia of Criterium are currently collaborating with our investigators and leading pharmaceutical partners on a number of exciting trials.

The following are clinical trials conducted by AMyC member and affiliate sites. Please click on the link in each listing to view the trial information at

Relapsed/Refractory Multiple Myeloma / Ph I
IMGN901 in Combination with Lenalidomide and Dexamethasone in Patients with CD56-positive Relapsed or Relapsed/Refractory Multiple Myeloma
Clinical Trial ID NCT00991562

Relapsed/Refractory Multiple Myeloma / Phase I/II
A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Clinical Trial ID NCT01464034

Newly Diagnosed Multiple Myeloma / Ph Ib
A Safety Study of Carfilzomib With Cyclophosphamide and Dexamethasone Prior to Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma.
Clinical Trial ID NCT01660750

Systemic Light Chain Amyloidosis / Ph I
A Safety Study of Carfilzomib in Patients with Previously-Treated Systemic Light Chain Amyloidosis.
Clinical Trial ID NCT01789242